Protalix BioTherapeutics to Report Third Quarter 2022 Financial and Business Results on November 14, 2022
- Monday, November 7, 2022, 7:11
- PR Newswire
- Add a comment
Company to host conference call and webcast at 8:30 a.m. EST CARMIEL, Israel, Nov. 7, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic…
About the Author
admin has written 20652 stories on this site.